Finerenone mitigates type 1 diabetic cardiomyopathy via modulation of cardiac macrophage–fibroblast crosstalk

31 August 2026 (13:27 - 13:39)
Organised by: Logo
Congress Presentation Part of: Cardiometabolic interactions and adipose tissue crosstalk Drugs, Drug Targets ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology